Clinical Trial Update: Comparing RadiaPlexRx Hydrogel and Standard-of-Care for Radiation Dermatitis in Breast Cancer Patients [Phase 3]

View source ↗

Summary

Phase 3 trial comparing RadiaPlexRx Hydrogel to standard care for radiation dermatitis in breast cancer patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Radiation Dermatitis

Drugs mentioned

• RadiaPlexRx Hydrogel
• Standard of Care

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Radiation Dermatitis | Phase 3 | Status: COMPLETED